The difficult-to-treat electroconvulsive therapy patient - Strategies for augmenting outcomes

被引:31
|
作者
Loo, Colleen K. [1 ,2 ,3 ]
Kaill, Andrew [2 ]
Paton, Pauline [2 ]
Simpson, Brett [2 ]
机构
[1] Univ NSW, Sch Psychiat, Sydney, NSW, Australia
[2] St George Hosp, SE Sydney Illawarra Hlth, Sydney, NSW, Australia
[3] Black Dog Inst, Sydney, NSW, Australia
基金
英国医学研究理事会;
关键词
Electroconvulsive therapy; Depression; Treatment resistance; Remifentanil; Hyperventilation; SEIZURE DURATION; ANTIDEPRESSANT DRUGS; WEEKLY ECT; HYPERVENTILATION; REMIFENTANIL; EFFICACY; ALFENTANIL; ANESTHESIA; PROPOFOL; SAFETY;
D O I
10.1016/j.jad.2009.07.011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Several treatment strategies for augmenting outcomes with ECT (concurrent antidepressant treatment, frequency of ECT treatments, hyperventilation and use of remifentanil) are discussed in the context of a difficult clinical case, accompanied by a review of the relevant existing literature. Methods: Literature on the above aspects of ECT technique was identified via a PubMed search and was critically reviewed. Results: There is preliminary evidence that concurrent administration of some antidepressant medications may be useful in the highly treatment resistant patient, though due attention should be given to potential risks in combining these with ECT; reduction of the treatment frequency to twice a week; hyperventilation prior to each treatment; and the use of remifentanil to minimise the dosage of induction anaesthetics with anticonvulsant properties, may be useful strategies to enhance seizure production in cases where a high or rapidly rising seizure threshold is a major impediment to ECT treatment. Limitations: It should be noted that empirical evidence for the effectiveness of each of the above strategies in producing better outcomes with ECT is not definitive, pointing to the need for further research in these areas. Conclusions: The above strategies may be useful in clinical ECT practice, particularly in patients who are apparently treatment resistant, but the practitioner should be aware that the level of evidence underpinning these approaches is at present, preliminary. Crown Copyright (C) 2009 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:219 / 227
页数:9
相关论文
共 50 条
  • [41] Prevalence, Characteristics, Management, and Outcomes of Difficult-to-Treat Inflammatory Bowel Disease
    Parigi, Tommaso Lorenzo
    Massimino, Luca
    Carini, Alfredo
    Gabbiadini, Roberto
    Bertoli, Peter
    Allocca, Mariangela
    Bezzio, Cristina
    Dal Buono, Arianna
    D'Amico, Ferdinando
    Furfaro, Federica
    Loy, Laura
    Zilli, Alessandra
    Ungaro, Federica
    Jairath, Vipul
    Peyrin-Biroulet, Laurent
    Armuzzi, Alessandro
    Danese, Silvio
    JOURNAL OF CROHNS & COLITIS, 2024,
  • [42] Long-term outcomes in difficult-to-treat patients with recurrent pericarditis
    Brucato, Antonio
    Brambilla, Giovanni
    Moreo, Antonella
    Alberti, Antonella
    Munforti, Carlotta
    Ghirardello, Anna
    Doria, Andrea
    Shinar, Yael
    Livneh, Avi
    Adler, Yehuda
    Shoenfeld, Yehuda
    Maurl, Francesco
    Palmieri, Giancarlo
    Spodick, David H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (02): : 267 - 271
  • [43] Disorganized Attachment: A Compass for Navigating the Confusing Behavior of the “Difficult-to-Treat” Patient
    Nancy Gubman
    Clinical Social Work Journal, 2004, 32 : 159 - 169
  • [44] Disorganized attachment: A compass for navigating the confusing behavior of the "difficult-to-treat" patient
    Gubman, N
    CLINICAL SOCIAL WORK JOURNAL, 2004, 32 (02) : 159 - 169
  • [45] Expanding possibilities in the treatment of patient groups with previously difficult-to-treat patients
    Dorener, Thomas
    Burmester, Gerd R.
    CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (03) : 235 - 236
  • [46] Multiple Bone Fractures in a Patient With Difficult-to-Treat Cushing?s Disease
    Correia, Sara
    Ramalho, Diogo
    Rocha, Gustavo
    Oliveira, Maria J.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [47] Management of difficult-to-treat depression with anxiety
    Papakostas, George
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 324 - 324
  • [48] Olanzapine and fluoxetine in difficult-to-treat depressions
    Dubé, S
    Corya, SA
    Tollefson, GD
    Andersen, SW
    Risser, RC
    Case, M
    Briggs, SD
    Tohen, M
    JOURNAL OF AFFECTIVE DISORDERS, 2004, 78 : S48 - S49
  • [49] Systematic assessment of difficult-to-treat asthma
    Robinson, DS
    Campbell, DA
    Durharm, SR
    Pfeffer, J
    Barnes, PJ
    Chung, KF
    EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (03) : 478 - 483
  • [50] Management of difficult-to-treat inhibitor patients
    Giangrande, P. L. F.
    Escobar, M. A.
    HAEMOPHILIA, 2010, 16 : 52 - 57